Langerhans cell histiocytosis

Langerhans cell histiocytosis is a rare disorder where the body makes too many immature Langerhans cells. These cells are a type of white blood cell that normally helps your immune system fight infections. When too many of these cells build up, they can damage tissues and organs.

The condition can affect just one part of the body or spread to multiple organs. It most commonly appears in bones, skin, lungs, liver, and the pituitary gland. The severity ranges from mild cases that go away on their own to serious cases that need ongoing treatment.

This disorder can happen at any age but is most common in children between 1 and 15 years old. Adults can also develop it, though it is less common. The exact number of people affected is hard to estimate because many mild cases never get diagnosed.

• Bone pain or fractures, especially in the skull, ribs, or long bones
• Skin rashes that look scaly, red, or like seborrheic dermatitis
• Chronic ear infections or ear drainage that does not respond to antibiotics
• Loose teeth or swollen gums
• Bulging eyes or vision problems
• Excessive thirst and frequent urination from diabetes insipidus
• Shortness of breath or chronic cough
• Enlarged liver or spleen
• Unexplained fever or weight loss
• Swollen lymph nodes

Some people with mild, localized disease may have no symptoms at all. Others experience symptoms only in the affected organ. The pattern of symptoms depends on which parts of the body are involved.

The exact cause of Langerhans cell histiocytosis is not fully understood. Research shows that many cases involve mutations in genes that control cell growth, particularly the BRAF gene. These mutations cause Langerhans cells to multiply out of control and accumulate in tissues. The condition is not inherited in most cases. Instead, these genetic changes happen randomly during a person's lifetime.

Risk factors are not well established because the condition is so rare. It affects slightly more males than females. There is no clear link to environmental exposures, infections, or lifestyle factors. Some researchers are studying whether the condition has features of both cancer and immune disorders, but classification remains challenging.

Diagnosing Langerhans cell histiocytosis requires a tissue biopsy. A doctor will remove a small sample of affected tissue and examine it under a microscope. Special stains and tests look for specific markers that identify Langerhans cells, such as CD1a and langerin proteins.

Genetic testing can identify mutations in the BRAF gene, which are present in about half of all cases. This specialized testing helps confirm the diagnosis and may guide treatment decisions. Imaging tests like X-rays, CT scans, or MRI scans help doctors see which organs are involved. Blood tests check for complications like anemia, liver problems, or hormone imbalances. Talk to your doctor about testing if you have symptoms that concern you.

• Watchful waiting for mild, single-site disease that may resolve on its own
• Surgical removal or curettage of isolated bone lesions
• Chemotherapy for multisystem disease or cases that do not respond to other treatments
• Targeted therapy drugs like BRAF inhibitors for cases with BRAF mutations
• Radiation therapy in select cases where surgery is not possible
• Hormone replacement therapy for pituitary gland damage causing diabetes insipidus
• Steroids or other medications to reduce inflammation
• Regular monitoring with imaging and blood tests to check disease activity